- Markets
- Healthcare
- KAYA
KAYA
New to Zerodha? Sign-up for free.
New to Zerodha? Sign-up for free.
-
Share Price
-
Financials
-
Revenue mix
-
Shareholdings
-
Peers
-
Forensics
- 5D
- 1M
- 6M
- YTD
- 1Y
- 5Y
- MAX
This data is currently unavailable for this company.
-
Summary
-
Profit & Loss
-
Balance sheet
-
Cashflow
This data is currently unavailable for this company.
(In Cr.) |
---|
(In Cr.) | ||||
---|---|---|---|---|
This data is currently unavailable for this company. |
(In %) |
---|
(In Cr.) |
---|
Financial Year (In Cr.) |
---|
-
Product wise
-
Location wise
Revenue Mix
This data is currently unavailable for this company.
Revenue Mix
This data is currently unavailable for this company.
Recent events
-
News
-
Corporate Actions
India's Kaya gains on collaboration with Marico
** Shares of Kaya KAYA.NS rise 10% to 499.5 rupees
** The skin and hair care products maker said late Wednesday it will collaborate with consumer goods maker Marico MRCO.NS which will exclusively handle sales and marketing of Kaya's products
** Shares of MRCO up 0.2%
** KAYA up ~48% so far this year, eyes best yearly gain since Dec. 2021
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
** Shares of Kaya KAYA.NS rise 10% to 499.5 rupees
** The skin and hair care products maker said late Wednesday it will collaborate with consumer goods maker Marico MRCO.NS which will exclusively handle sales and marketing of Kaya's products
** Shares of MRCO up 0.2%
** KAYA up ~48% so far this year, eyes best yearly gain since Dec. 2021
(Reporting by Ashna Teresa Britto in Bengaluru)
(([email protected] ; ( +91 8078332441))
Kaya Says Kaya Middle East Fze Has Entered Into A Joint Venture With Khimjis Ramdas
Nov 3 (Reuters) - Kaya Ltd KAYA.NS:
KAYA MIDDLE EAST FZE HAS ENTERED INTO A JOINT VENTURE WITH KHIMJIS RAMDAS
KAYA MIDDLE EAST FZE WILL HOLD 51% IN KHIMJIS HEALTH CARE IN OMAN
DEAL FOR 102,000 OMR
Further company coverage: KAYA.NS
(([email protected];))
Nov 3 (Reuters) - Kaya Ltd KAYA.NS:
KAYA MIDDLE EAST FZE HAS ENTERED INTO A JOINT VENTURE WITH KHIMJIS RAMDAS
KAYA MIDDLE EAST FZE WILL HOLD 51% IN KHIMJIS HEALTH CARE IN OMAN
DEAL FOR 102,000 OMR
Further company coverage: KAYA.NS
(([email protected];))
Kaya Approved Issue Of Equity Shares On Rights Issue Basis
Oct 24 (Reuters) - Kaya Ltd KAYA.NS:
APPROVED ISSUE OF EQUITY SHARES ON RIGHTS ISSUE BASIS
ISSUE OF SHARES FOR AN AMOUNT NOT EXCEEDING 3 BILLION RUPEES
Further company coverage: KAYA.NS
(([email protected];))
Oct 24 (Reuters) - Kaya Ltd KAYA.NS:
APPROVED ISSUE OF EQUITY SHARES ON RIGHTS ISSUE BASIS
ISSUE OF SHARES FOR AN AMOUNT NOT EXCEEDING 3 BILLION RUPEES
Further company coverage: KAYA.NS
(([email protected];))
Kaya Unit Enters Into Definitive Agreements To Sell Entire Holding In Minal Medical Centre Llcand M M C Skin Clinic Llc To Dr. Minal Patwardhan
Aug 24 (Reuters) - Kaya Ltd KAYA.NS:
UNIT ENTERED INTO DEFINITIVE AGREEMENTS TO SELL ENTIRE HOLDING IN MINAL MEDICAL CENTRE LLCAND M M C SKIN CLINIC LLC TO DR. MINAL PATWARDHAN
TO SELL ITS ENTIRE HOLDINGS TO MINAL PATWARDHAN, EXISTING PARTNER, WHO CURRENTLY HOLDS 28.33% IN BOTH SAID ENTITIES
CONSIDERATION TO BE RECEIVED BY SALE OF HOLDING IN MINAL MEDICAL CENTRE LLC AT AED 3.6 MILLION
CONSIDERATION TO BE RECEIVED BY SALE OF HOLDING IN M M C SKIN CLINIC LLC AT AED 0.1 MILLION
Source text for Eikon: ID:nNSE9lSdRj
Further company coverage: KAYA.NS
(([email protected];))
Aug 24 (Reuters) - Kaya Ltd KAYA.NS:
UNIT ENTERED INTO DEFINITIVE AGREEMENTS TO SELL ENTIRE HOLDING IN MINAL MEDICAL CENTRE LLCAND M M C SKIN CLINIC LLC TO DR. MINAL PATWARDHAN
TO SELL ITS ENTIRE HOLDINGS TO MINAL PATWARDHAN, EXISTING PARTNER, WHO CURRENTLY HOLDS 28.33% IN BOTH SAID ENTITIES
CONSIDERATION TO BE RECEIVED BY SALE OF HOLDING IN MINAL MEDICAL CENTRE LLC AT AED 3.6 MILLION
CONSIDERATION TO BE RECEIVED BY SALE OF HOLDING IN M M C SKIN CLINIC LLC AT AED 0.1 MILLION
Source text for Eikon: ID:nNSE9lSdRj
Further company coverage: KAYA.NS
(([email protected];))
Kaya Unit Acquired 100% Equity Stake In Kaya Beauty Clinic LLC SP
May 31 (Reuters) - Kaya Ltd KAYA.NS:
UNIT ACQUIRED 100% EQUITY STAKE IN KAYA BEAUTY CLINIC LLC SP
Source text for Eikon: ID:nBSE4jWTw9
Further company coverage: KAYA.NS
(([email protected];))
May 31 (Reuters) - Kaya Ltd KAYA.NS:
UNIT ACQUIRED 100% EQUITY STAKE IN KAYA BEAUTY CLINIC LLC SP
Source text for Eikon: ID:nBSE4jWTw9
Further company coverage: KAYA.NS
(([email protected];))
Events:
More Micro Cap Ideas
See similar 'Micro' cap companies with recent activity
Promoter Buying
Companies where the promoters are bullish
Capex
Companies investing on expansion
Superstar Investor
Companies where well known investors have invested
Popular questions
-
Business
-
Financials
-
Share Price
-
Shareholdings
What does Kaya do?
Kaya Ltd, located in Mumbai, is a skin care clinic chain offering a range of services including skin glow facials, anti-acne treatment, laser hair reduction, and hair care for men and women.
Who are the competitors of Kaya?
Kaya major competitors are Radix Industries (I), Lloyds Luxuries, JHS Svendgaard, Naturo Agrotech, Bajaj Corp, Zydus Wellness, Gillette India. Market Cap of Kaya is ₹363 Crs. While the median market cap of its peers are ₹278 Crs.
Is Kaya financially stable compared to its competitors?
Kaya seems to be less financially stable compared to its competitors. Altman Z score of Kaya is -1.36 and is ranked 8 out of its 8 competitors.
Does Kaya pay decent dividends?
The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Kaya latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%
How has Kaya allocated its funds?
Companies resources are majorly tied in miscellaneous assets
How strong is Kaya balance sheet?
Kaya balance sheet is weak and might have solvency issues
Is the profitablity of Kaya improving?
The profit is oscillating. The profit of Kaya is -₹7.77 Crs for TTM, -₹129.22 Crs for Mar 2024 and -₹116.47 Crs for Mar 2023.
Is the debt of Kaya increasing or decreasing?
The debt of Kaya is decreasing. Latest debt of Kaya is ₹117 Crs as of Sep-24. This is less than Mar-24 when it was ₹143 Crs.
Is Kaya stock expensive?
There is insufficient historical data to gauge this. Latest PE of Kaya is 0
Has the share price of Kaya grown faster than its competition?
Kaya has given lower returns compared to its competitors. Kaya has grown at ~-5.45% over the last 2yrs while peers have grown at a median rate of 7.72%
Is the promoter bullish about Kaya?
Promoters stake in the company seems stable, and we need to go through filings and allocation of resources to gauge promoter bullishness. Latest quarter promoter holding in Kaya is 59.64% and last quarter promoter holding is 59.64%.
Are mutual funds buying/selling Kaya?
There is Insufficient data to gauge this.